| Date |
Research Question / Title |
Unique ID |
Research Team |
|
October 29, 2021
|
Long COVID: What does it mean for the healthcare system and programs to deal with it?
|
EOC021901v2 RR Table
|
EOC
|
|
October 29, 2021
|
Long COVID: What does it mean for the healthcare system and programs to deal with it?
|
EOC021901v2 RR
|
EOC
|
|
October 21, 2021
|
Long COVID: What does it mean for the healthcare system and programs to deal with it?
|
EOC021901v2 ESR
|
EOC
|
|
July 12, 2021
|
What are long COVID's demands on the healthcare system, and its
severity of the illness?
|
EPM210602 RR Table
|
Epidemiology & Modelling
|
|
July 12, 2021
|
What are long COVID's demands on the healthcare system, and its
severity of the illness?
|
EPM210602 RR
|
Epidemiology & Modelling
|
|
July 9, 2021
|
What is the incidence and duration of Long COVID cases?
|
EPM210601 RR
|
Epidemiology & Modelling
|
|
July 9, 2021
|
What is the incidence and duration of long COVID cases?
|
EPM210601 RR Table
|
Epidemiology & Modelling
|
|
June 25, 2021
|
What is the incidence and duration of long COVID cases?
|
EPM210601 ESR
|
Epidemiology & Modelling
|
|
June 25, 2021
|
What are long COVID's demands on the healthcare system, and its
severity of the illness?
|
EPM210602 ESR
|
Epidemiology & Modelling
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR
|
EOC
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR Table
|
EOC
|
|
April 1, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 ESR
|
EOC
|
|
March 29, 2021
|
What impact does COVID-19 vaccination have on visitation policies and transmission rates in LTC?
|
LTC012501 RR
|
Long Term Care
|
|
March 8, 2021
|
What impact does COVID-19 vaccination have on visitation policies and transmission rates in LTC?
|
LTC012501v2-01 ESR
|
Long Term Care
|
|
February 26, 2021
|
What are the efficacies and outcomes of Point-of-Care/Antigen testing in Long Term care?
|
LTC020201 RR
|
Long Term Care
|
|
February 5, 2021
|
What are the efficacies and outcomes of Point-of-Care/Antigen testing in Long Term care?
|
LTC020201-01 ESR
|
Long Term Care
|
|
December 18, 2020
|
What is the risk of COVID-19 transmission during AGMP procedures?
|
PPE120901 RR
|
Personal Protective Equipment
|
|
December 13, 2020
|
What is the evidence for a 14 day isolation period upon move-in to a continuing care environment during the COVID-19 pandemic?
|
LTC090801 RR
|
Long Term Care
|
|
December 11, 2020
|
What is the risk of COVID-19 transmission during AGMP procedures?
|
PPE120901-01 ESR
|
Personal Protective Equipment
|
|
December 4, 2020
|
What is the evidence regarding limiting patient visitors in long-term care facilities to 2 or less, and how are other jurisdictions managing family caregivers?
|
LTC101501 RR
|
Long Term Care
|
